Metformin Increases Sensitivity of Pancreatic Cancer Cells to Gemcitabine by Reducing CD133+ Cell Populations and Suppressing ERK/P70S6K Signaling

Scientific Reports - United Kingdom
doi 10.1038/srep14404
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Hypoxia Increases Resistance of Human Pancreatic Cancer Cells to Apoptosis Induced by Gemcitabine

Clinical Cancer Research
Cancer ResearchOncology
2004English

CD133 Antisense Suppresses Cancer Cell Growth and Increases Sensitivity to Cisplatin in Vitro

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2012English

Cyclopentenyl Cytosine Increases Gemcitabine Radiosensitisation in Human Pancreatic Cancer Cells

British Journal of Cancer
Cancer ResearchOncology
2008English

YAP Inhibition by Resveratrol via Activation of AMPK Enhances the Sensitivity of Pancreatic Cancer Cells to Gemcitabine

Nutrients
NutritionFood ScienceDietetics
2016English

Silencing of B7-H3 Increases Gemcitabine Sensitivity by Promoting Apoptosis in Pancreatic Carcinoma

Oncology Letters
Cancer ResearchOncology
2013English

CCL21/CCR7 Axis Contributed to CD133+ Pancreatic Cancer Stem-Like Cell Metastasis via EMT and Erk/NF-κB Pathway

PLoS ONE
Multidisciplinary
2016English

Metformin Inhibit Cervical Cancer Migration by Suppressing the FAK/Akt Signaling Pathway

Asian Pacific Journal of Cancer Prevention
2019English

Metformin Restrains Pancreatic Duodenal Homeobox-1 (PDX-1) Function by Inhibiting ERK Signaling in Pancreatic Ductal Adenocarcinoma.

Current Molecular Medicine
BiochemistryMedicineMolecular MedicineMolecular Biology
2016English

Emodin Sensitizes Human Pancreatic Cancer Cells to EGFR Inhibitor Through Suppressing Stat3 Signaling Pathway

Cancer Management and Research
Oncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy